Strides Pharma Science Limited has informed the Exchange regarding Change in Director(s) of the company.
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Strides Pharma Science announced multiple leadership changes effective June 1, 2026. Ram (Venkata Seetharama Raju Pakalapati), currently COO, has been elevated to Executive Director and Board member, becoming a Key Managerial Personnel (KMP). Aditya Arun Kumar, son of Founder and Chairperson Arun Kumar, stepped down from his Executive Director role and KMP position but continues as a Non-Executive Director on the Board. Nandini Matiyani has been redesignated as Group CHRO and nominated as Senior Management Personnel (SMP). Ariff Khan, Executive VP Manufacturing Operations, has also been nominated as SMP. The changes are part of the company's succession planning and professionalization of management.
The promotion of internal talent (Ram) to the Board signals healthy succession planning. Aditya's transition from executive to non-executive role, while remaining connected to the promoter family, suggests ongoing professionalization of management structure.